Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SOLARA Stock Analysis
Views
Red Flags
Positive
Low and declining Debt to Equity
Company's earnings are of high quality
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Low ROE but improving trend
Low operating margin but improving trend
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SOLARA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SOLARA Bulk, Block & Insider Trades
SOLARA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(1 new shares @ 375 INR for 3 existing shares)Rights ISIN INE624Z20016. Ex-date: 15th May 2024 Announced on: 9th May 2024
Company Profile
Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product catego... Read More
Key personnel
Mr. Sandeep Shashikantha RaoD
Chief Executive Officer, Managing Director, Executive Director
Mr. Sarat Kumar
Chief Financial Officer
Dr. Sudhir Nambiar
Chief Scientific Officer (Head R&D)
Ms. Pooja Jaya Kumar
Chief Compliance Officer, Company Secretary
Mr. Mohanraj S.D
Additional Whole Time Director
Mr. Vishal Mathur
Chief Business Officer
Mr. V. Sundara Moorthy
Chief Quality Officer
Mr. Manish GuptaD
Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Solara Active Pharma Sciences Ltd.?
The current share price of Solara Active Pharma Sciences Ltd. is ₹ 547.67 as of 09 Jan 2026.
What is the PE ratio of Solara Active Pharma Sciences Ltd.?
The Price-to-Earnings (PE) ratio of Solara Active Pharma Sciences Ltd. is 309.06 as of the latest financial data.
What is the ROE and ROCE of Solara Active Pharma Sciences Ltd.?
Solara Active Pharma Sciences Ltd. has a Return on Equity (ROE) of 0.55% and a Return on Capital Employed (ROCE) of 5.11% as per the latest financial reports.
What is the market cap of Solara Active Pharma Sciences Ltd.?
The market capitalization of Solara Active Pharma Sciences Ltd. stands at ₹ 1,981.09 Cr.
What is the dividend yield of Solara Active Pharma Sciences Ltd.?
The dividend yield of Solara Active Pharma Sciences Ltd. is 0.00% based on the current market price.
What is the RSI of Solara Active Pharma Sciences Ltd.?
The Relative Strength Index (RSI) of Solara Active Pharma Sciences Ltd. is 41.18.
What is the FII and DII holding in Solara Active Pharma Sciences Ltd.?
Foreign Institutional Investors (FII) hold 13.58% and Domestic Institutional Investors (DII) hold 1.21% of Solara Active Pharma Sciences Ltd. shares.
What sector does Solara Active Pharma Sciences Ltd. belong to?
Solara Active Pharma Sciences Ltd. operates in the Healthcare sector.
What is the beta of Solara Active Pharma Sciences Ltd. stock?
The beta of Solara Active Pharma Sciences Ltd. stock is 1.15, indicating its volatility relative to the broader market.
